Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Cell Biology: Research & TherapyISSN: 2324-9293
Min Li Author
Subjects of specialization
Affiliation
Neurosurgery,Cancer Research,Biology & Pharmacology
Department of Neurosurgery, The University of Texas Medical School at Houston
Biography
Min Li, Ph.D. Associate Professor, Director of Cancer Research Program The Vivian L. Smith Department of Neurosurgery, Department of Integrative Biology & Pharmacology, The University of Texas Medical School at Houston
Publications
Editorial Open Access
Inflammation and Pancreatic Cancer: A Tale of Two Cytokines
Author(s): Wei Li, Andrew M. Albrecht, and Min Li
Inflammation and Pancreatic Cancer: A Tale of Two Cytokines
Pancreatic cancer is the most fatal of all gastrointestinal (GI) cancers, with only a 5.8% survival rate beyond five years after initial diagnosis. This cancer is characterized by a high mortality, rapid progression, and resistance to chemo and radiation therapy. Surgical resection is the only curative treatment for pancreatic cancer, but only less than 15% patients are eligible for surgery. The front-line treatment for metastatic pancreatic cancer has been adjuvant chemotherapy trials of gemcitabine and gemcitabine-based combinational therapy. However, over the past decade, no significant advances in efficacy of ... view more»
Social Media